Comment C5 Re: insta-dupe

Story

The dawning of the age of genomic medicine, finally

Preview

insta-dupe (Score: 4, Interesting)

by danieldvorkin@pipedot.org on 2014-03-08 17:55 (#B4)

Over on Soylent, someone pointed out that this story was published almost simultaneously there and on Slashdot as well as here, and didn't seem particularly happy about it. Guilty; I submitted the story to each site because I think it's an interesting and important topic, and I honestly didn't expect it to be published in all three places. Do people object to this? If so, I won't do it any more, but I'd like to know what our evolving community's standard will be.

Re: insta-dupe (Score: 2, Interesting)

by bryan@pipedot.org on 2014-03-10 08:02 (#C5)

At Soylent's staff meeting last week they agreed to forbid editors (just editors, not members) from cross-posting stories to the different news-for-nerds sites. This had the obvious effect of reducing new story submissions on Pipedot. Of course, some stories are just too popular to not get reported everywhere, and I have no problems with dupes slipping through.

I have to admit, though, it's a little annoying to find a worthy news item, write up a story about it, submit it, then notice that the green/red sites already have a similar story posted.

Moderation

Time Reason Points Voter
2014-03-12 06:21 Interesting +1 ploling@pipedot.org

Junk Status

Not marked as junk